These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8528401)

  • 21. [Current developments in hybridoma technology].
    Osterhaus AD; UytdeHaag AG
    Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
    Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M; Sasamori E; Chiba T; Hanyu Y
    J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation of human monoclonal antibodies reactive with human melanoma and the possibility of clinical application].
    Yamaguchi H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1677-84. PubMed ID: 2835935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
    Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM
    Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of Epstein-Barr virus transformation for the production of human monoclonal antibodies.
    Roome AJ; Reading CL
    Exp Biol; 1984; 43(1):35-55. PubMed ID: 6099808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of antigen-specific antibody-secreting cells.
    Kishi H; Jin A; Ozawa T; Tajiri K; Obata T; Muraguchi A
    Methods Mol Biol; 2012; 853():141-50. PubMed ID: 22323145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion.
    Pratt M; Mikhalev A; Glassy MC
    Hybridoma; 1987 Oct; 6(5):469-77. PubMed ID: 3500113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of stable heterohybridomas producing human monoclonal antibodies.
    Cooper MD; Kirkpatrick R
    Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
    [No Abstract]   [Full Text] [Related]  

  • 32. [Increase of lymphocytes producing antibodies against rabies virus, using intrasplenic adoptive transfer in mice treated with cyclophosphamide].
    Lara-Sagahon V; Ciprian CA; Aguilar-Setien A
    Arch Invest Med (Mex); 1989; 20(3):263-72. PubMed ID: 2633721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human X human hybridoma producing monoclonal antibody against autologous cervical carcinoma.
    Hagiwara H; Sato GH
    Mol Biol Med; 1983 Sep; 1(2):245-52. PubMed ID: 6334217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro stimulation of human peripheral blood B cells from normal individuals by activated T cells increases the efficiency of hybridoma generation.
    Ferraro AS; Newkirk MM
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):80-5. PubMed ID: 8100151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immortalization of magnetically separated human lymphocytes by electrofusion.
    Glaser RW; Volk HD; Liebenthal C; Jahn S; Grunow R
    Hum Antibodies Hybridomas; 1990; 1(2):111-4. PubMed ID: 1715775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
    Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P
    J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus in rheumatoid arthritis.
    Fox RI; Lotz M; Rhodes G; Vaughan JH
    Clin Rheum Dis; 1985 Dec; 11(3):665-88. PubMed ID: 3000687
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
    Chiorazzi N; Wasserman RL; Kunkel HG
    J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human hybridoma neutralizing antibodies to the herpes simplex virus].
    Kushch AA; Tugizov ShM; Terletskaia EN; Posevaia TA; Nikitina AA; L'vov ND; Barinskiĭ IF
    Vopr Virusol; 1992; 37(5-6):264-6. PubMed ID: 1337804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.